Keybank National Association Neurocrine Biosciences Inc Transaction History

Keybank National Association

  • $25.6 Billion
  • Q4 2024

A detailed history of Keybank National Association transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Keybank National Association holds 3,095 shares of NBIX stock, worth $362,672. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,095
Previous 3,588 13.74%
Holding current value
$362,672
Previous $413,000 2.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025
SELL
$111.62 - $139.44 $55,028 - $68,743
-493 Reduced 13.74%
3,095 $422,000
Q3 2024

Oct 31, 2024
BUY
$114.58 - $153.15 $60,841 - $81,322
531 Added 17.37%
3,588 $413,000
Q2 2024

Jul 31, 2024
BUY
$130.86 - $143.19 $187,784 - $205,477
1,435 Added 88.47%
3,057 $420,000
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $261,843 - $288,629
-2,008 Reduced 55.32%
1,622 $223,000
Q4 2023

Feb 13, 2024
SELL
$106.07 - $132.76 $42,321 - $52,971
-399 Reduced 9.9%
3,630 $478,000
Q3 2023

Nov 08, 2023
BUY
$94.02 - $117.1 $29,616 - $36,886
315 Added 8.48%
4,029 $453,000
Q2 2023

Aug 01, 2023
SELL
$89.53 - $104.87 $173,598 - $203,342
-1,939 Reduced 34.3%
3,714 $350,000
Q1 2023

May 10, 2023
SELL
$94.11 - $123.02 $97,497 - $127,448
-1,036 Reduced 15.49%
5,653 $572,000
Q4 2022

Jan 31, 2023
SELL
$106.72 - $127.06 $93,486 - $111,304
-876 Reduced 11.58%
6,689 $798,000
Q3 2022

Oct 27, 2022
SELL
$92.03 - $107.81 $20,154 - $23,610
-219 Reduced 2.81%
7,565 $803,000
Q2 2022

Aug 08, 2022
BUY
$75.79 - $100.07 $78,139 - $103,172
1,031 Added 15.27%
7,784 $759,000
Q1 2022

Apr 28, 2022
SELL
$72.45 - $94.81 $182,646 - $239,016
-2,521 Reduced 27.18%
6,753 $633,000
Q4 2021

Feb 07, 2022
BUY
$79.65 - $106.22 $557 - $743
7 Added 0.08%
9,274 $790,000
Q3 2021

Nov 08, 2021
BUY
$86.18 - $99.03 $98,503 - $113,191
1,143 Added 14.07%
9,267 $889,000
Q2 2021

Aug 12, 2021
SELL
$89.43 - $102.27 $48,113 - $55,021
-538 Reduced 6.21%
8,124 $791,000
Q1 2021

May 07, 2021
SELL
$87.57 - $119.4 $107,098 - $146,026
-1,223 Reduced 12.37%
8,662 $842,000
Q4 2020

Feb 09, 2021
SELL
$86.91 - $108.33 $3,650 - $4,549
-42 Reduced 0.42%
9,885 $947,000
Q3 2020

Oct 29, 2020
BUY
$96.16 - $135.15 $468,106 - $657,910
4,868 Added 96.22%
9,927 $955,000
Q2 2020

Aug 10, 2020
BUY
$85.09 - $130.36 $430,470 - $659,491
5,059 New
5,059 $617,000

Others Institutions Holding NBIX

# of Institutions
643
Shares Held
94.7M
Call Options Held
615K
Put Options Held
570K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email